Blog: The Brain Dialogues, filtered by tag: Genetics

Research Officer in CHeBA’s Genetics & Epigenomics Group, Naga Mutyala, completed her PhD in March 2020 which focused on evaluating a rodent model and novel treatments for glioblastoma, a grade IV brain cancer, using gene expression profiling.  Glioblastoma is the most lethal grade of brain cancer in adults and resultantly has very poor patient outcomes with a median survival rate of only 15 months. To improve treatment success further evaluation of alternative therapies is urgently required. Therefore, we examined the efficacy of an antipsychotic drug olanzapine as an alternative… Read More